Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 214 results:
Συντάκτης [ Τίτλος] Τύπος Έτος Φίλτρα: Συντάκτης is Liakopoulos, Vassilios [Clear All Filters]
Hemodiafiltration does not have additional benefits over hemodialysis on arterial stiffness, wave reflections and central aortic pressures..
Blood Purif. 37(1), 18-26.
(2014). Hemodialysis patients with intradialytic rise in blood pressure display higher baseline aortic stiffness and negligible drop in augmentation index with dialysis..
Int Urol Nephrol. 48(4), 601-8.
(2016). Hemodialysis-related changes in phenotypical features of monocytes..
Sci Rep. 8(1), 13964.
(2018). Home blood pressure-guided antihypertensive therapy in chronic kidney disease: more data are needed..
J Am Soc Hypertens. 12(4), 242-247.
(2018). Hypertension in Chronic Kidney Disease: Novel Insights..
Curr Hypertens Rev. 16(1), 45-54.
(2020). Hypertension in Dialysis Patients: Diagnostic Approaches and Evaluation of Epidemiology..
Diagnostics (Basel). 12(12),
(2022). Icodextrin-associated generalized exfoliative skin rash in a CAPD patient: a case-report..
BMC Nephrol. 19(1), 293.
(2018). IDO decreases glycolysis and glutaminolysis by activating GCN2K, while it increases fatty acid oxidation by activating AhR, thus preserving CD4+ T‑cell survival and proliferation..
Int J Mol Med. 42(1), 557-568.
(2018). The impact of OSA and CPAP treatment on cell adhesion molecules' night-morning variation..
Sleep Breath.
(2020). The Importance of Icodextrin Use for Technique and Patient Survival in Peritoneal Dialysis..
Am J Kidney Dis. 72(2), 309.
(2018). In human alloreactive CD4⁺ T-cells, dichloroacetate inhibits aerobic glycolysis, induces apoptosis and favors differentiation towards the regulatory T-cell subset instead of effector T-cell subsets..
Mol Med Rep. 13(4), 3370-6.
(2016). In Mixed Lymphocyte Reaction, the Hypoxia-Inducible Factor Prolyl-Hydroxylase Inhibitor Roxadustat Suppresses Cellular and Humoral Alloimmunity..
Arch Immunol Ther Exp (Warsz). 68(6), 31.
(2020). Increased Indoleamine 2,3-Dioxygenase in Monocytes of Patients on Hemodialysis..
Iran J Kidney Dis. 10(2), 91-3.
(2016). Increased plasma angiogenin level is associated and may contribute to decreased T-cell zeta-chain expression in hemodialysis patients..
Ther Apher Dial. 17(1), 48-54.
(2013). Increased visfatin in hemodialysis patients is associated with decreased demands for recombinant human erythropoietin..
Ren Fail. 35(10), 1399-403.
(2013). In-Depth Bioinformatic Study of the CLDN16 Gene and Protein: Prediction of Subcellular Localization to Mitochondria..
Medicina (Kaunas). 55(8),
(2019). Indoleamine 2, 3-dioxygenase Up-regulates Hypoxia-inducible Factor-1α Expression by Degrading L-tryptophan but Not Its Activity in Human Alloreactive T-cells..
Iran J Allergy Asthma Immunol. 17(1), 56-67.
(2018). Indoleamine 2,3-dioxygenase, by degrading L-tryptophan, enhances carnitine palmitoyltransferase I activity and fatty acid oxidation, and exerts fatty acid-dependent effects in human alloreactive CD4+ T-cells..
Int J Mol Med. 38(5), 1605-1613.
(2016). Indoleamine 2,3-dioxygenase controls purinergic receptor-mediated ischemia-reperfusion injury in renal tubular epithelial cells..
J Basic Clin Physiol Pharmacol.
(2022). Indoleamine 2,3-dioxygenase depletes tryptophan, activates general control non-derepressible 2 kinase and down-regulates key enzymes involved in fatty acid synthesis in primary human CD4+ T cells..
Immunology. 146(2), 292-300.
(2015). Indoleamine 2,3-dioxygenase increases p53 levels in alloreactive human T cells, and both indoleamine 2,3-dioxygenase and p53 suppress glucose uptake, glycolysis and proliferation..
Int Immunol. 26(12), 673-84.
(2014). Indoleamine 2,3-dioxygenase is increased in hemodialysis patients and affects immune response to hepatitis B vaccination..
Vaccine. 29(12), 2242-7.
(2011). Indoleamine 2,3-dioxygenase suppresses humoral alloimmunity via pathways that different to those associated with its effects on T cells..
Biomed Rep. 1(1), 1-5.
(2019).
(2013).
(2013).